Ravi Iyer

Ravi Iyer

Company: Script Biosciences

Job title: Chief Scientific Officer


Rectification of Frameshift Mutations in Duchenne Muscular Dystrophy by Casplus, a Novel CRISPR-Based High Efficiency Genome Editing Technology 5:00 pm

SCRIPT Biosciences presents CasPlus, a novel gene editing technology for high efficiency genome editing CasPlus demonstrates reduced risk of large on-target deletions and chromosomal translocations CasPlus corrects mutations and knockout pathological genes We showcase the application of CasPlus for the rectification of frameshift mutations in Duchenne Muscular Dystrophy (DMD)Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.